SONENREICH STEVEN D exercised Options for 7,671 BioStem Technologies, Inc. shares at $0/share, and the transaction left him with 7,671 shares. For BSEM investors, the ownership record shows the position as shares rather than derivative securities, with 0 derivative securities after the transaction.

Key Highlights

  • The transaction was dated 2026-08-27.
  • The recorded transaction code was M.
  • The post-transaction record listed 0 derivative securities.

SONENREICH STEVEN D exercised options covering 7,671 BioStem Technologies, Inc. (NASDAQ: BSEM) shares at $0/share. The post-transaction record lists his ownership at 7,671 shares.

Transaction Details and Ownership Record

SONENREICH STEVEN D is identified as an insider of BioStem Technologies, Inc. The options exercise was recorded on 2026-08-27 under SEC transaction code M. The transaction involved derivative securities tied to BioStem Technologies, Inc. Following the exercise, SONENREICH STEVEN D owned 7,671 shares. His recorded derivative-securities ownership stood at 0 after the transaction.

Post-Transaction Shares and Derivative Securities

The ownership record separates the resulting share position from derivative securities. SONENREICH STEVEN D’s post-transaction holdings were listed as 7,671 shares, while derivative securities were listed at 0. The exercise price for the options was $0/share.